HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED

Clinical trials for HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED explained in plain language.

Never miss a new study

Get alerted when new HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED trials appear

Sign up with your email to follow new studies for HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Promising breast cancer combo trial for elderly pulled before start

Disease control Terminated

This study aimed to test the safety and effectiveness of adding the drug ribociclib to standard hormone therapy and radiation for women aged 70 and older with a certain type of breast cancer. The goal was to control the disease without surgery. However, the trial was withdrawn be…

Matched conditions: HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED

Phase: PHASE1, PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control

Last updated May 12, 2026 13:40 UTC

HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED

Get alerted when new HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED trials appear

Promising breast cancer combo trial for elderly pulled before start